Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about TAK
Recent news which mentions TAK
< Previous
1
2
3
4
5
6
7
8
9
Next >
Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs
May 08, 2025
Tickers
NEWS
TAK
Tags
Benzinga
General
why it's moving
From
Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
Tickers
AAOI
ABCL
ABEV
ABL
Tags
CRVS
DCGO
AQMS
From
Benzinga
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients
April 02, 2025
Tickers
NEWS
PFE
TAK
Tags
Briefs
Market News
Health Care
From
Benzinga
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
March 27, 2025
Tickers
AAPG
NEWS
TAK
Tags
Biotech
Initiation
Expert Ideas
From
Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
March 21, 2025
Tickers
AMGN
AZN
BIIB
BMY
Tags
Stories That Matter
RHHBY
BIIB
From
Benzinga
Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer
March 03, 2025
Tickers
NEWS
PTGX
TAK
Tags
TAK
why it's moving
General
From
Benzinga
Earnings Scheduled For January 30, 2025
January 30, 2025
Tickers
AAPL
ABCB
ABG
AJG
Tags
SCSC
CVCO
PHM
From
Benzinga
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
January 28, 2025
Tickers
NBIX
NEWS
TAK
Tags
General
TAK
Top Stories
From
Benzinga
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
January 15, 2025
Tickers
ABT
COST
FOOD
GIS
Tags
GIS
Benzinga
Top Stories
From
Benzinga
Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency
December 27, 2024
Tickers
ASIA
NEWS
TAK
Tags
TAK
why it's moving
General
From
Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
Tickers
MRK
NEWS
RHHBY
SNY
Tags
Price Target
Pharmaceutical
RHHBY
From
Benzinga
Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst
December 03, 2024
Tickers
KROS
NEWS
TAK
Tags
Benzinga
Contracts
Analyst Ratings
From
Benzinga
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
November 14, 2024
Tickers
ACIU
NEWS
TAK
Tags
Health Care
News
Trading Ideas
From
Benzinga
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
November 12, 2024
Tickers
F
FAN
ICLN
NEWS
Tags
Events
TAK
Benzinga
From
Benzinga
Preview: Takeda Pharmaceutical's Earnings
October 30, 2024
Tickers
TAK
Tags
TAK
Market News
BZI/EP
From
Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
October 17, 2024
Tickers
ALMS
BMY
NEWS
TAK
Tags
Analyst Color
Health Care
Trading Ideas
From
Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
October 04, 2024
Tickers
JNJ
NEWS
TAK
Tags
Biotech
Stories That Matter
Benzinga
From
Benzinga
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
September 10, 2024
Tickers
JNJ
NEWS
PTGX
TAK
Tags
Health Care
Analyst Color
News
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
RHHBY
Stories That Matter
AZN
From
Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
September 06, 2024
Tickers
HKMPF
HKMPY
MCKPF
MNKTQ
Tags
News
Large Cap
TEVA
From
Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
August 12, 2024
Tickers
ASND
NEWS
TAK
Tags
Health Care
News
Trading Ideas
From
Benzinga
Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
August 07, 2024
Tickers
NEWS
TAK
Tags
Top Stories
Benzinga
General
From
Benzinga
TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q1 2024
July 31, 2024
Tickers
TAK
Tags
TAK
Earnings Reports
Market News
From
InvestorPlace
3 Biotech Stocks to Buy on the Dip: July 2024
July 29, 2024
Tickers
JAZZ
PCRX
TAK
Tags
PCRX
Market News
NASDAQ:JAZZ,NYSE:TAK,NASDAQ:PCRX
From
InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
July 24, 2024
Tickers
ALMS
BMY
JNJ
NEWS
Tags
Health Care
Analyst Color
News
From
Benzinga
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
July 09, 2024
Tickers
LLY
MORF
NEWS
TAK
Tags
Large Cap
News
M&A
From
Benzinga
Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report
July 02, 2024
Tickers
BX
LBO
NEWS
PSP
Tags
BX
AI Generated
Stories That Matter
From
Benzinga
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
June 18, 2024
Tickers
BTDR
LEN
NEE
NEWS
Tags
URGN
Benzinga
VRE
From
Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 17, 2024
Tickers
AAN
AGRI
ALLG
AMCX
Tags
PRMW
Losers
VERO
From
Benzinga
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
June 17, 2024
Tickers
NEWS
OVID
TAK
Tags
Benzinga
why it's moving
General
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.